Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differently

Vivian de Waard, Ilze Bot, Saskia C. A. de Jager, Sara Talib, Kensuke Egashira, Margreet R. de Vries, Paul H. A. Quax, Erik A. L. Biessen, Theo J. C. van Berkel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)84-89
JournalAtherosclerosis
Volume211
Issue number1
DOIs
Publication statusPublished - Jul 2010

Keywords

  • Aneurysm
  • MCP1
  • CCR2
  • Leukocytes
  • STAT5

Cite this

de Waard, V., Bot, I., de Jager, S. C. A., Talib, S., Egashira, K., de Vries, M. R., Quax, P. H. A., Biessen, E. A. L., & van Berkel, T. J. C. (2010). Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differently. Atherosclerosis, 211(1), 84-89. https://doi.org/10.1016/j.atherosclerosis.2010.01.042